The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double the intended dose of Levetiracetam, leading to severe adverse effects, Dr Reddy’s notified.
The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double the intended dose of Levetiracetam, leading to severe adverse effects, Dr Reddy’s notified.